8
Treatment/Management of GCA
Figure 1. Key Recommendations for the Treatment of GCA
Active GCA
High-dose IV pulse GC followed by high-dose
daily oral GC with TCZ over GC alone; In some
instances, can consider GC with MTX or
GC alone
Consider adding or
changing non-GC
immunosuppressive
agent (e.g., MTX or
ABA instead of TCZ)
Taper daily oral GC
Visual symptoms/loss or
critical cranial ischemia
Treatment option,
Conditional recommendation
Treatment option,
Strong recommendation
Disease status decision point
Assessed disease status
Clinical
remission
NO YES
